For ''N''-alkyl amphetamines, [[deamination]] and ''N''-[[dealkylation]] are the major elimination pathways and [[renal]] [[excretion]] is a minor one.<ref>{{cite journal |doi=10.1016/0009-8981(71)90187-2 |title=Deuterium isotope effects in the metabolism of n-alkylsubstituted amphetamines in man |date=September 1971 |last1=Vree |first1=T.B. |last2=Gorgels |first2=J.P.M.C. |last3=Muskens |first3=A.Th.J.M. |last4=Van Rossum |first4=J.M. |journal=Clinica Chimica Acta |volume=34 |issue=2 |pages=333â€“44 |pmid=5113570}}</ref>

 
Following the ban on [[ethylphenidate]] authorities noticed an increase in methiopropamine use by injecting users. The [[ACMD]] suggested it be banned on 18 November 2015<ref name="MPA report">{{cite web | url=https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/479996/23_November_-_TCDO_Report_for_MPA.pdf | title=Methiopropamine (MPA): A review of the evidence of use and harm | publisher=UK Home Office | date=25 November 2015 | accessdate=27 November 2015 | author=Advisory Council on the Misuse of Drugs | format=pdf}}</ref> as it had similar effects to ethylphenidate. The government enacted a [[temporary class drug|temporary drug control order]] a week later which came into force on 27 November 2015.<ref>{{cite web | url=http://www.legislation.gov.uk/uksi/2015/1929/made | title=The Misuse of Drugs Act 1971 (Temporary Class Drug) (No. 3) Order 2015 | publisher=UK Government | date=23 November 2015}}</ref> Though ordinarily the TCDO would only last 1 year, the ACMD reported that since its invocation prevalence of MPA had significantly decreased, and that it had been challenging to collect information about the drug. As a result of this, they requested that the TCDO be extended a further year.<ref name="Aug 2016 ACMD rec">{{Cite web |url=https://www.gov.uk/government/publications/temporary-class-drug-order-on-methiopropamine |title=Re: Temporary Class Drug Order on methiopropamine |year=2016 |access-date=2016-11-28}}</ref>
